Daniela Trisciuoglio Selected Research

Daniela Trisciuoglio Research Topics

Disease

48	Neoplasms (Cancer) 07/2022 - 03/2002
16	Melanoma (Melanoma, Malignant) 01/2021 - 09/2002
10	Hypoxia (Hypoxemia) 01/2015 - 09/2002
5	Breast Neoplasms (Breast Cancer) 10/2020 - 02/2004
4	Glioblastoma (Glioblastoma Multiforme) 05/2020 - 08/2007
3	Carcinogenesis 07/2021 - 10/2009
3	Neoplasm Metastasis (Metastasis) 10/2020 - 12/2005
3	Lung Neoplasms (Lung Cancer) 06/2020 - 10/2014
3	Leukemia 05/2020 - 01/2012
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 07/2014 - 01/2012
2	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 02/2020
2	Neuroblastoma 12/2021 - 01/2012
2	Adenocarcinoma 11/2019 - 10/2014
2	Sarcoma (Soft Tissue Sarcoma) 11/2018 - 02/2018
2	Glioma (Gliomas) 01/2017 - 09/2008
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2016 - 10/2014
2	Colorectal Neoplasms (Colorectal Cancer) 09/2008 - 01/2008
1	Triple Negative Breast Neoplasms 10/2020
1	Rhabdomyosarcoma 05/2020
1	Prostatic Neoplasms (Prostate Cancer) 01/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 11/2019
1	Myxoid Liposarcoma 11/2018
1	Liposarcoma 11/2018
1	Genomic Instability 01/2018
1	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2016

Drug/Important Bio-Agent (IBA)

25	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2004
9	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2020 - 09/2002
6	TubulinIBA 12/2021 - 01/2012
5	Transcription Factors (Transcription Factor)IBA 12/2021 - 09/2002
5	Histone Deacetylase InhibitorsIBA 05/2020 - 05/2013
5	Messenger RNA (mRNA)IBA 04/2019 - 09/2002
4	EnzymesIBA 12/2021 - 01/2015
4	Pharmaceutical PreparationsIBA 10/2020 - 11/2018
4	Conditioned Culture MediaIBA 06/2020 - 11/2003
4	Histones (Histone)IBA 01/2018 - 01/2012
3	Protein Isoforms (Isoforms)IBA 12/2021 - 07/2010
3	Biomarkers (Surrogate Marker)IBA 07/2021 - 01/2016
3	Histone Acetyltransferases (Histone Acetyltransferase)IBA 06/2020 - 03/2016
3	MicroRNAs (MicroRNA)IBA 02/2020 - 12/2016
3	Antisense OligonucleotidesIBA 11/2004 - 11/2003
2	Histone DemethylasesIBA 07/2022 - 04/2019
2	Lysine AcetyltransferasesIBA 06/2020 - 01/2016
2	Biological ProductsIBA 05/2020 - 01/2016
2	Decitabine FDA Link 02/2020 - 11/2019
2	DNA (Deoxyribonucleic Acid)IBA 02/2020 - 02/2004
2	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2018 - 07/2014
2	givinostat hydrochlorideIBA 02/2018 - 10/2014
2	SirtuinsIBA 01/2018 - 02/2016
2	ThiazolesIBA 03/2016 - 01/2012
2	Hypoxia-Inducible Factor 1IBA 11/2013 - 07/2010
2	Interleukin-8 (Interleukin 8)IBA 09/2009 - 11/2008
2	matrigelIBA 08/2007 - 12/2005
2	Matrix Metalloproteinases (MMPs)IBA 12/2005 - 09/2004
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 09/2005 - 02/2004
1	Apoptosis Regulatory ProteinsIBA 01/2022
1	venetoclaxIBA 01/2022
1	Aurora KinasesIBA 12/2021
1	PHA 680626IBA 12/2021
1	Aurora Kinase AIBA 12/2021
1	pyrvinium (Vankin)FDA Link 10/2020
1	LipidsIBA 10/2020
1	Angiogenesis InhibitorsIBA 06/2020
1	Cadherins (E-Cadherin)IBA 05/2020
1	MethyltransferasesIBA 02/2020
1	Azacitidine (5 Azacytidine)FDA Link 02/2020
1	quinolineIBA 02/2020
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2020
1	efavirenz (Sustiva)FDA Link 01/2020
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2020
1	2- (sec- butylthio)- 6- (1- (2,6- difluorophenyl)propyl)- 5- methylpyrimidin- 4(3H)- oneIBA 01/2020
1	Chemotactic FactorsIBA 01/2020
1	Culture MediaIBA 01/2020
1	DNA Transposable Elements (Element, IS)IBA 01/2020
1	Reverse Transcriptase InhibitorsIBA 01/2020
1	CytokinesIBA 01/2020
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2020
1	NucleotidesIBA 11/2019
1	pyrimidineIBA 11/2019
1	ResveratrolIBA 01/2019
1	Semaphorins (Semaphorin)IBA 11/2018
1	ChromatinIBA 11/2018
1	Proto-Oncogene Proteins c-mybIBA 11/2018
1	VimentinIBA 11/2018
1	RNA (Ribonucleic Acid)IBA 11/2018
1	TrabectedinIBA 11/2018
1	NAD (NADH)IBA 01/2018
1	Oncogene Proteins (Oncogene Protein)IBA 01/2018
1	AcetyltransferasesIBA 01/2018
1	Small Interfering RNA (siRNA)IBA 12/2017
1	Caspase 8 (Caspase-8)IBA 01/2017
1	Transient Receptor Potential ChannelsIBA 12/2016
1	HydrazonesIBA 03/2016
1	Sirtuin 1IBA 02/2016
1	Lysine (L-Lysine)FDA Link 01/2016
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 06/2015
1	A-factor (Streptomyces)IBA 06/2015

Therapy/Procedure

24	Therapeutics 01/2022 - 03/2002
3	Drug Therapy (Chemotherapy) 12/2021 - 01/2008
1	Precision Medicine 07/2021
1	Adjuvant Chemotherapy 11/2018